FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

CDER Commits to 11 Drug Quality Guides in 2025

[ Price : $8.95]

CDER posts its latest guidance agenda that shows it is committing to issuing 11 drug quality guidance documents in 2025.

FDA Complete Response on Ataras Ebvallo

[ Price : $8.95]

FDA sends Atara Biotherapeutics a complete response letter on its BLA for Ebvallo (tabelecleucel), a monotherapy treatment for adu...

Anti-Neuropathy Guidance for Cancer Drugs

[ Price : $8.95]

FDA publishes a draft guidance on developing drugs to prevent and treat cancer-related chemotherapy-induced peripheral neuropathy.

FDA Seeks Comments on Cannabis Use in Animals

[ Price : $8.95]

Federal Register notice: FDA seeks public comments on the use of cannabis-derived products (CDPs) in animals.

Commissioners Suggestions for Martin Makary

[ Price : $8.95]

FDA commissioner Robert Califf and three former commissioners offer their perspectives on the ways the incoming administration can...

Boehringer Schizophrenia Cognition Trial Misses Endpoints

[ Price : $8.95]

Boehringer Ingelheim reports disappointing data from its CONNEX clinical trial program evaluating iclepertin in cognitive impairme...

Medline Fluid Delivery Sets Recalled

[ Price : $8.95]

Medline Industries recalls its Medline Fluid Delivery Set with Drip Chamber because the devices were incorrectly assembled.

FDA Early Alert on Fresenius Pump Software Updates

[ Price : $8.95]

Citing potentially lethal risk, an FDA Early Alert says Fresenius Kabi is recommending updates to some software for its Ivenix Inf...

FDA Warns Against Using Epinephrine Nasal Solution

[ Price : $8.95]

An FDA alert warns healthcare professionals not to use unapproved epinephrine nasal solutions manufactured by BPI Labs and Endo US...